[Intravitreal triamcinolone acetonide treatment in diabetic macular edema].
OBJECTIVE
To assess the efficacy and safety of intravitreal triamcinolone acetonide in diabetic macular oedema.


METHODS
prospective study; 76 patients, 102 eyes; preoperative assessment: visual acuity, intraocular pressure, fundus biomicroscopy fluoresceine angiography, sometimes OCT; postoperative assessment: visual acuity, intraocular pressure, fundus biomicroscopy, fluoresceine angiography, sometimes OCT.


RESULTS
Visual acuity improvement in 42% cases; subjective improvement of visual acuity in 72% of cases


CONCLUSIONS
Triamcinolon acetonide may play a role in treatment of diabetic macular oedema.
Spitalul Universitar de Urgenţă Militar Central "Dr. Carol Davila" Bucureşti.
M
M
Zemba
B
B
Cucu
Camelia
C
Manole
Veronica
V
Enache
D003930:Diabetic Retinopathy / Q000150:complications / Q000188:drug therapy*; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D058449:Intravitreal Injections; D008269:Macular Edema / Q000188:drug therapy* / Q000209:etiology; D011182:Postoperative Care; D011300:Preoperative Care; D011446:Prospective Studies; D018570:Risk Assessment; D016896:Treatment Outcome; D014222:Triamcinolone Acetonide / Q000008:administration & dosage*; D014792:Visual Acuity
D005938:Glucocorticoids; D014222:Triamcinolone Acetonide